scispace - formally typeset
R

Robert Hemmings

Researcher at McGill University Health Centre

Publications -  69
Citations -  2401

Robert Hemmings is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Pregnancy & Follicular phase. The author has an hindex of 23, co-authored 63 publications receiving 2211 citations. Previous affiliations of Robert Hemmings include McGill University & Université de Montréal.

Papers
More filters
Journal Article

Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome.

TL;DR: Endometrial lymphocytes of recurrent spontaneous aborters harbor a distinct immunophenotypic profile that antedates implantation and suggests that endometrial immunologic conditions are intrinsically altered in recurrent aborters, as well as suggesting a role for NK cells in the abortion process.
Journal ArticleDOI

Advanced Reproductive Age and Fertility

TL;DR: This guideline reviews options for the assessment of ovarian reserve and fertility treatments using ART with women of advanced reproductive age presenting with infertility and improves awareness of the natural age-related decline in female and male fertility.
Journal ArticleDOI

Advanced Reproductive Age and Fertility: No. 269, November 2011

TL;DR: To improve awareness of the natural age‐related decline in female and male fertility with respect to natural fertility and assisted reproductive technologies (ART), and to review investigations in the assessment of ovarian aging.
Journal ArticleDOI

Evaluation of risk factors associated with endometriosis.

TL;DR: Results indicated a positive association between endometriosis and education level for subjects who underwent hysterectomy, and underline the importance of taking into account the clinical profile of subjects when investigating risk factors for endometiosis.
Journal ArticleDOI

The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility

TL;DR: Recommendations are expected to allow adequate management of women with fibroids and infertility, maximizing their chances of pregnancy by minimizing risks introduced by unnecessary myomectomies and decreasing costs to the health care system.